Recursion Pharmaceuticals: Premium Valuation Without Proof (Rating Downgrade)

Recursion Pharmaceuticals shows high cash burn, limited efficacy data, and unproven platform validation. Check out why RXRX ...
pharmaphorum

AI biotechs Exscientia and Recursion agree $688m merger

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Google’s AI discovers yet another Chrome JavaScript vulnerability

Google has also provided Chrome for Android 141.0.7390.122, which fixes the same vulnerabilities as in the desktop versions.

Jim Cramer on Recursion Pharmaceuticals: “Now, It’s a Meme Stock”

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer was focused on recently. A caller asked if the ...
NFL

Dart's extended escape act ends in a 7-yard completion

New York Giants quarterback Jaxson Dart rolls right, avoids pressure and comes back to his left before finding wide receiver ...